Financials

News Ideas Discussions Technicals Seasonals

NRX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of NUREXONE BIOLOGIC INC

Total assets of NRX for Q2 24 is 4.50 M CAD, 19.63% less than the previous Q1 24. And total liabilities increased by 38.38% in Q2 24 to 868.9 k CAD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: CAD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—